Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

105962

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	IVF
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to reduce variation in the price of IVF cycles between clinical commissioning groups.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	212894
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>For National Health Service funded in-vitro fertilisation treatment, it is for clinical commissioning groups to decide with which fertility clinics to contract and agree the price payable with the service provider.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 17:39:40 answering member 3918 label Biography information for Jane Ellison
	tabling member	4079 label Biography information for Julian Sturdy

114825

	registered interest
	date	05/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to sections 105 and 120 of NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review, published in November 2014, which members of (a) NHS England's staff and (b) the Clinical Reference Group made up the project team; from where the focus group was drawn; and what the names are of those who sat on that focus group.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	213582
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>The Walton Centre NHS Foundation Trust, based in Liverpool, provided the cost information referenced in Section 121 of NHS England's <em>Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review</em>, published on 3 November 2014.</p><p> </p><p> </p><p> </p><p>Two separate consultation (focus group) meetings were held and chaired by Mr Sean Duffy, NHS England’s National Clinical Director for Cancer, involving members of the Radiotherapy Clinical Reference Group (CRG), Adult Neurosurgery CRG, Brain and Central Nervous System CRG, Neurosciences CRG and Stereotactic Radiosurgery CRG to agree key principles and options. Details of the membership of each of the CRGs are set out on the NHS England website at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/" target="_blank">http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 213583 question first answered 10/11/2014 17:16:16 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

114828

	registered interest
	date	05/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to section 121 of NHS England's Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review, published in November 2014, what the names are of those who supplied the data demonstrating (a) the cost effectiveness of treating patients surgically as against treating with stereotactic radiosurgery, (b) the cost of providing surgical treatment and (c) the cost of providing stereotacic radiosurgery.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	213583
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>The Walton Centre NHS Foundation Trust, based in Liverpool, provided the cost information referenced in Section 121 of NHS England's <em>Stereotactic Radiosurgery and Radiotherapy Services Needs Assessment and Service Review</em>, published on 3 November 2014.</p><p> </p><p> </p><p> </p><p>Two separate consultation (focus group) meetings were held and chaired by Mr Sean Duffy, NHS England’s National Clinical Director for Cancer, involving members of the Radiotherapy Clinical Reference Group (CRG), Adult Neurosurgery CRG, Brain and Central Nervous System CRG, Neurosciences CRG and Stereotactic Radiosurgery CRG to agree key principles and options. Details of the membership of each of the CRGs are set out on the NHS England website at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/" target="_blank">http://www.england.nhs.uk/ourwork/d-com/spec-serv/crg/</a></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 213582 question first answered 10/11/2014 17:16:16 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

114831

	registered interest
	date	05/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to NHS England's agreement to provide £6 million of funding for Cancer Research UK's Stereotactic Ablative Radiotherapy (SABR) clinical trial programme, (a) over what time period that funding will be available, (b) how many patients in total will take part in that trial, (c) how many of those patients will receive SABR and (d) what the cost per patient will be.
	tabling member constituency	Wells
	tabling member printed	Tessa Munt
	uin	213584
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>The majority of the trials in the Cancer Research UK (CRUK) Stereotactic Ablative Radiotherapy (SABR) clinical trial programme run over three years, although some extend to five.</p><p> </p><p> </p><p> </p><p>CRUK has approved five United Kingdom-wide trials to date, and a sixth is being considered in November 2014. The current assessment of the number of patients that will be recruited to the trials is a provisional estimate and it is important to note that this will vary dependent on a number of factors, including local recruitment and randomisation to different trial arms.</p><p> </p><p> </p><p> </p><p>The current trial protocols indicate that around two thirds of patients will be allocated to SABR trial arms.</p><p> </p><p> </p><p> </p><p>NHS England is providing a package of support of up to £6 million to trusts that are participating in the CRUK trials. The support package for SABR, for each participating trust will vary dependent on the fractionation used within the trial, but has been developed using the existing tariff structure for external beam radiotherapy as its basis.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 16:05:22 answering member 3918 label Biography information for Jane Ellison
	tabling member	4089 label Biography information for Tessa Munt

105975

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Interpreters
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the NHS spent on interpreters in hospitals in England and Wales in the last five years.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	uin	212950
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>I refer the hon. Member to the reply I gave him on 13 October 2014 to Question <a href="http://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2014-09-09/208666/" target="_blank">208666</a></p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 10/11/2014 16:58:50 answering member 1439 label Biography information for Norman Lamb
	tabling member	1597 label Biography information for David Simpson

105976

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Compensation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what strategy his Department has to reduce compensation claims within the NHS.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	uin	212951
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>In March 2014, my Rt. hon Friend the Secretary of State for Health issued a call to action to make the National Health Service the safest healthcare system in the world and achieve a three-year goal to halve avoidable harm and save 6,000 lives. The Sign up to Safety campaign embodies the ambition of the NHS to build a culture of safety, bringing together individuals and organisations with a contribution to make towards the patient safety goal. Elements of this campaign will focus on a reduction in avoidable harm that can lead to compensation claims. Organisations that sign up are setting out what they will do to strengthen patient safety, including a safety improvement plan which shows how their organisation intends to save lives and reduce harm for patients over the next three years. The NHS Litigation Authority (NHS LA) will support those organisations which have patient safety improvement plans that demonstrate a reduction in their higher volume, higher value claims.</p><p> </p><p> </p><p> </p><p>The NHS LA also provides a safety and learning service to its members, sharing information on the learning from claims with individual trusts and across the NHS to support learning and improvements in safety, and reduce harm. It also incentivises members to reduce claims by rewarding safer organisations with fewer, less costly claims through reduced contributions.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 10/11/2014 11:58:40 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1597 label Biography information for David Simpson

105977

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Strokes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent assessment he has made of the adequacy of support services for stroke survivors.
	tabling member constituency	Upper Bann
	tabling member printed	David Simpson
	uin	212948
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>The Sentinel Stroke National Audit Programme, run by the Royal College of Physicians and funded through the Healthcare Quality Improvement Partnership, aims to improve the quality of stroke care by auditing stroke services against evidence based standards.</p><p> </p><p> </p><p> </p><p>We know that when stroke survivors leave hospital, it is important that the right services are in place to ensure they have the support they need to make the best possible recovery. The audit shows that about 40% of stroke survivors are discharged with plans for on-going rehabilitation from a specialist team and that progress continues to be made in terms of the intensity of therapy provided by all of the disciplines (occupational, physiotherapy and speech and language therapy).</p><p> </p><p> </p><p> </p><p>However, there is still progress to be made and the cardiovascular disease Strategic Clinical Networks continue to work with commissioners and providers to improve stroke rehabilitation services.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 16:50:48 answering member 3918 label Biography information for Jane Ellison
	tabling member	1597 label Biography information for David Simpson

105992

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Cycling: Accidents
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many people were admitted to hospital following injuries by cyclists riding on footpaths in each of the last two years for which information is available; and if he will make a statement.
	tabling member constituency	Southend West
	tabling member printed	Mr David Amess
	uin	212994
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>This information is not collected. The Health and Social Care Information Centre has advised that it is not possible to identify accidents occurring specifically on footpaths within the Hospital Episode Statistics data.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 16:25:28 answering member 3918 label Biography information for Jane Ellison
	tabling member	44 label Biography information for Sir David Amess

105971

	registered interest
	date	03/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Ebola
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many UK health workers have gone to West Africa to help tackle the Ebola virus.
	tabling member constituency	South Antrim
	tabling member printed	Dr William McCrea
	uin	212924
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>The Chief Medical Officer wrote to National Health Service medical and nursing directors on 19 September seeking volunteers to help efforts on the ground in West Africa. Currently over 1000 NHS staff and 185 staff from Public Health England have put their names forward through UK MED which runs the <em>UK International Emergency Medical Register </em>(UKIEMR).</p><p> </p><p> </p><p> </p><p>The programme comprises a robust selection process, pre-deployment vaccinations and occupational health and psychological screening, training in the UK with further training and mentoring in Sierra Leone, and advice and support on monitoring health on return. We do not expect everyone on the register to be deployed.</p><p> </p><p> </p><p> </p><p>We do not know how many UK health care workers are currently deployed with non-governmental organisations on the ground in West Africa.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 17:29:12 answering member 3918 label Biography information for Jane Ellison
	tabling member	655 label Biography information for Lord McCrea of Magherafelt and Cookstown

106304

	registered interest
	date	04/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prostate Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that the quality of care for prostate cancer patients improves across the country.
	tabling member constituency	Pudsey
	tabling member printed	Stuart Andrew
	uin	213237
	answer	answer is ministerial correction date of answer 10/11/2014 answer text <p>The Government’s Mandate to NHS England sets out an ambition to make England one of the most successful countries in Europe at preventing premature deaths from all cancers, including prostate cancer. Cancer indicators in the NHS Outcomes Framework and the Public Health Outcomes Framework will help NHS England to assess progress in improving cancer survival and mortality for men with prostate cancer.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) Referral Guidelines for Suspected Cancer (2005) are available to help general practitioners (GPs) assess when it is appropriate to refer patients for suspected cancer, including prostate cancer. NICE is in the process of updating the guidelines to ensure that these reflect latest evidence and can continue to support GPs to identify patients with suspected cancer symptoms and urgently refer them as appropriate. NICE’s anticipated publication date for the revised guidelines is May 2015.</p><p> </p><p> </p><p> </p><p>At a local level, it is for individual clinical commissioning groups to promote and enhance the diagnostic capability to deliver better outcomes. Surgery, radiotherapy and chemotherapy treatments that may be used for prostate cancer are commissioned at the moment by NHS England. NHS England’s prostate cancer service specification clearly defines what it expects to be in place for providers to offer evidence-based, safe and effective prostate cancer services. This service specification has been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe core and developmental service standards.</p><p> </p><p> </p><p> </p><p>The NICE published an updated clinical guideline on the diagnosis and treatment of prostate cancer in January 2014. NICE has recommended docetaxel, abiraterone and enzalutamide as treatment options for some types of prostate cancer, subject to certain clinical criteria and is currently appraising a number of other prostate cancer drugs. Patients have the right to drugs and treatments that have been recommended by NICE technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate. A number of drugs to treat prostate cancer are available through the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p>To help reduce regional variations, the Care Quality Commission (CQC) is increasingly incorporating information from accreditation and peer review programmes into its assessments of NHS trusts' services for the treatment of prostate cancer. This includes the national cancer peer review programme, which encompasses prostate cancer. The cancer patient survey also asks specific questions on having a specialist nurse. The CQC intends to use data from the national clinical audit which is being developed for prostate cancer. In addition, national statistics on waiting times experienced by patients with suspected and diagnosed cancers continue to be collected, monitored and published in order to improve equity of access to cancer services and to contribute to an improvement in survival rates.</p><p> </p><p> </p><p> </p><p>This Government is also investing in innovative radiotherapy treatments to improve outcomes for those with cancer. NHS England has also committed to make up to £6 million available over the next three years to support six trials by Cancer Research UK into the use of Stereotactic Ablative Body Radiotherapy (SABR). This will allow patients to receive SABR treatment now, where clinicians think they could benefit. At the same time doctors can fully assess the effectiveness of these treatments so that in future, if it proves to be effective, they will be available for all relevant patients on the NHS. Two of these six trials will be on prostate cancer.</p><p> </p><p> </p><p> </p><p>We have also invested £23 million across 50 United Kingdom centres aimed at increasing the capacity of radiotherapy centres in England to deliver Intensity Modulated Radiotherapy (IMRT). We committed to achieving the ambition of 24% of all radiotherapy to be delivered through more accurate IMRT, and we are now seeing 35% of all radical radiotherapy treatments delivered using this method compared to 5% in 2010.</p><p> </p><p> </p><p> </p><p>The National Prostate Cancer Audit (NCPA) First Year Annual Report was published on the 10 November. The report covers the work undertaken since April 2013. It includes a preliminary analysis of the NPCA’s organisational audit, an analysis of existing data sets including patients with prostate cancer in England, and the design of the NPCA’s prospective audit dataset. The findings from the audit will contribute to changes in clinical practice ensuring that patients receive the best care possible and experience an improved quality of life. The audit is funded by the Department and has been commissioned by the Healthcare Quality Improvement Partnership.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 10/11/2014 17:53:50 answering member 3918 label Biography information for Jane Ellison
	tabling member	4032 label Biography information for Stuart Andrew